Shinsuke Kurokawa

446 total citations
32 papers, 245 citations indexed

About

Shinsuke Kurokawa is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Oncology. According to data from OpenAlex, Shinsuke Kurokawa has authored 32 papers receiving a total of 245 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 10 papers in Rheumatology and 9 papers in Oncology. Recurrent topics in Shinsuke Kurokawa's work include Renal cell carcinoma treatment (8 papers), Prostate Cancer Diagnosis and Treatment (6 papers) and Prostate Cancer Treatment and Research (6 papers). Shinsuke Kurokawa is often cited by papers focused on Renal cell carcinoma treatment (8 papers), Prostate Cancer Diagnosis and Treatment (6 papers) and Prostate Cancer Treatment and Research (6 papers). Shinsuke Kurokawa collaborates with scholars based in Japan. Shinsuke Kurokawa's co-authors include Tatsuo Morita, Taro Kubo, Akinori Nukui, Akihiko Tokue, Kazuhiko Nakano, Minoru Kobayashi, Minoru Kobayashi, Hitoshi Ando, Akio Fujimura and Keiko Hosohata and has published in prestigious journals such as SHILAP Revista de lepidopterología, Medicine and Toxicology.

In The Last Decade

Shinsuke Kurokawa

30 papers receiving 241 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shinsuke Kurokawa Japan 8 110 104 70 45 35 32 245
Taketoshi Nara Japan 10 151 1.4× 78 0.8× 83 1.2× 43 1.0× 64 1.8× 42 277
Shuai Hu China 10 123 1.1× 81 0.8× 63 0.9× 77 1.7× 46 1.3× 18 310
Zijian Tian China 10 81 0.7× 31 0.3× 75 1.1× 52 1.2× 43 1.2× 33 244
Chuan-Shu Chen Taiwan 12 146 1.3× 54 0.5× 141 2.0× 96 2.1× 78 2.2× 52 339
Fucai Tang China 11 205 1.9× 54 0.5× 169 2.4× 52 1.2× 96 2.7× 40 367
Fengbin Gao China 10 77 0.7× 65 0.6× 136 1.9× 110 2.4× 94 2.7× 17 332
Dexin Dong China 8 92 0.8× 32 0.3× 111 1.6× 66 1.5× 53 1.5× 20 260
Ching‐Chia Li Taiwan 13 139 1.3× 64 0.6× 100 1.4× 159 3.5× 67 1.9× 30 376
Gracinda Costa Portugal 10 65 0.6× 59 0.6× 40 0.6× 46 1.0× 15 0.4× 31 302
Seung Taek Lim South Korea 12 41 0.4× 127 1.2× 52 0.7× 101 2.2× 55 1.6× 35 324

Countries citing papers authored by Shinsuke Kurokawa

Since Specialization
Citations

This map shows the geographic impact of Shinsuke Kurokawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shinsuke Kurokawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shinsuke Kurokawa more than expected).

Fields of papers citing papers by Shinsuke Kurokawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shinsuke Kurokawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shinsuke Kurokawa. The network helps show where Shinsuke Kurokawa may publish in the future.

Co-authorship network of co-authors of Shinsuke Kurokawa

This figure shows the co-authorship network connecting the top 25 collaborators of Shinsuke Kurokawa. A scholar is included among the top collaborators of Shinsuke Kurokawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shinsuke Kurokawa. Shinsuke Kurokawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ando, Satoshi, Jun Kamei, Masahiro Yamazaki, et al.. (2021). Longer preserved urethral length in robot‐assisted radical prostatectomy significantly contributes to post‐operative urinary continence recovery. SHILAP Revista de lepidopterología. 3(2). 184–190. 5 indexed citations
2.
Takayama, Tatsuya, Akifumi Fujita, Toru Sugihara, et al.. (2021). Natural history of asymptomatic renal artery pseudoaneurysm after robot-assisted partial nephrectomy. Translational Andrology and Urology. 10(9). 3555–3565. 1 indexed citations
3.
Kurokawa, Shinsuke, Jun Kamei, Koichi Sakata, et al.. (2020). Questionnaire survey assessing seasonal changes in lower urinary tract symptoms in men with benign prostate hyperplasia. SHILAP Revista de lepidopterología. 46(6). 468–473.
4.
Kameda, Tomohiro, Tatsuya Takayama, Toru Sugihara, et al.. (2020). The efficacy of axitinib as a first‐line treatment for metastatic renal cell carcinoma. Asia-Pacific Journal of Clinical Oncology. 16(4). 241–246. 3 indexed citations
5.
6.
Ando, Hitoshi, Kazuhiko Nakano, Kentaro Ushijima, et al.. (2016). Influence of genetic polymorphisms of multidrug and toxin extrusion protein 1 on its mRNA expression in peripheral blood cells. Journal of Pharmacological Sciences. 131(2). 138–140. 1 indexed citations
7.
8.
Hosohata, Keiko, Satoshi Washino, Taro Kubo, et al.. (2016). Early prediction of cisplatin-induced nephrotoxicity by urinary vanin-1 in patients with urothelial carcinoma. Toxicology. 359-360. 71–75. 28 indexed citations
9.
Nakano, Kazuhiko, Hitoshi Ando, Shinsuke Kurokawa, et al.. (2015). Association of decreased mRNA expression of multidrug and toxin extrusion protein 1 in peripheral blood cells with the development of flutamide-induced liver injury. Cancer Chemotherapy and Pharmacology. 75(6). 1191–1197. 4 indexed citations
10.
Kurokawa, Shinsuke, et al.. (2014). Torricelli-Bernoulli Sign in a Large Intestine Gastrointestinal Stromal Tumor. Internal Medicine. 53(21). 2547–2547. 4 indexed citations
11.
Nakano, Kazuhiko, Taro Kubo, Akinori Nukui, et al.. (2014). External validation of risk classification in patients with docetaxel-treated castration-resistant prostate cancer. BMC Urology. 14(1). 31–31. 12 indexed citations
12.
Nakano, Kazuhiko, Katsuko Komatsu, Taro Kubo, et al.. (2013). Hand-Foot Skin Reaction is Associated with the Clinical Outcome in Patients with Metastatic Renal Cell Carcinoma Treated with Sorafenib. Japanese Journal of Clinical Oncology. 43(10). 1023–1029. 35 indexed citations
13.
14.
Nakano, Kazuhiko, Shigeyuki Ohta, Taro Kubo, et al.. (2012). Docetaxel with or without estramustine for estramustine refractory castration-resistant prostate cancer: a single institution experience. BMC Urology. 12(1). 3–3. 7 indexed citations
15.
Kobayashi, Minoru, Akinori Nukui, Kazumi Suzuki, Shinsuke Kurokawa, & Tatsuo Morita. (2011). Clinical efficacy of primary combined androgen blockade for Japanese men with clinically localized prostate cancer unsuitable for local definitive treatment: a single institution experience. International Journal of Clinical Oncology. 16(6). 630–636. 3 indexed citations
16.
Kobayashi, Minoru, Shinsuke Kurokawa, & Akihiko Tokue. (2005). Intraindividual Variation in Total and Percent Free Prostate-Specific Antigen Levels in Prostate Cancer Suspects. Urologia Internationalis. 74(3). 198–202. 7 indexed citations
17.
Yashi, Masahiro, Akinori Nukui, Shinsuke Kurokawa, et al.. (2003). Elevated serum progastrin‐releasing peptide (31–98) level is a predictor of short response duration after hormonal therapy in metastatic prostate cancer. The Prostate. 56(4). 305–312. 20 indexed citations
18.
Morita, Tatsuo, et al.. (2003). Forced Expression of Cytidine Deaminase Confers Sensitivity to Capecitabine. Oncology. 65(3). 267–274. 24 indexed citations
19.
Kurokawa, Hideo, et al.. (1972). Radiotherapy for eosinophilic granuloma of the soft tissue (Kimura's disease).. PubMed. 144(4). 407–13. 7 indexed citations
20.
Kobayashi, Shunsuke, et al.. (1969). [Case of the cervical esophagus developing cancer after radiotherapy].. PubMed. 15(6). 567–70. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Taketoshi Nara Breakdown of academic impact, for papers by Shuai Hu Breakdown of academic impact, for papers by Zijian Tian Breakdown of academic impact, for papers by Chuan-Shu Chen Breakdown of academic impact, for papers by Fucai Tang Breakdown of academic impact, for papers by Fengbin Gao Breakdown of academic impact, for papers by Dexin Dong Breakdown of academic impact, for papers by Ching‐Chia Li Breakdown of academic impact, for papers by Gracinda Costa Breakdown of academic impact, for papers by Seung Taek Lim
Rankless by CCL
2026